Translational Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2022-10-02 ms5000000443448137

大家with editor一般多久呀，这个杂志怎么效率这么低呀

51 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2023-07-14 ms9000000796006851 来自江苏省

偏重的研究方向：癌症
经验分享：没人审稿啊

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2023-07-04 bochia 来自陕西省

with editor已经15天了，写信没有任何回复。

22 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2023-01-05 ms1000000761154155 来自湖南省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：历时三个月左右，一次大修一次小修，成功接收！

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2023-05-15 ms9000001676536897 来自江苏省

偏重的研究方向：肿瘤;生信
经验分享：这个期刊生信加实验还收吗?

29 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2021-08-09 146a1aa7m17(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;预测
经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2022-08-16 ms5000000443448137

感觉速度略慢，外审已经两个月……

54 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2023-01-06 MasterYeung 来自河北省

偏重的研究方向：肿瘤
经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2022-12-25 148999f2m69暂无昵称来自陕西省

with editor 已经20天了

42 0

[GetPortalCommentsPageByObjectIdResponse(id=2091537, encodeId=1210209153ef8, content=大家with editor一般多久呀，这个杂志怎么效率这么低呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Sun Oct 02 23:55:53 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148064, encodeId=1e38214806495, content=偏重的研究方向：癌症 经验分享：没人审稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0798142938, createdName=ms9000000796006851, createdTime=Fri Jul 14 19:30:10 CST 2023, time=2023-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2108902, encodeId=5d30210890237, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：历时三个月左右，一次大修一次小修，成功接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f9f5591944, createdName=ms1000000761154155, createdTime=Thu Jan 05 10:34:18 CST 2023, time=2023-01-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239162, encodeId=f9be1239162ff, content=感觉速度略慢，外审已经两个月……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Tue Aug 16 23:48:29 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109066, encodeId=1b542109066d4, content=偏重的研究方向：肿瘤 经验分享：required reviews completed这一步是干啥呢，也没有看到审稿意见，有人了解嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65385491887, createdName=MasterYeung, createdTime=Fri Jan 06 13:59:04 CST 2023, time=2023-01-06, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107389, encodeId=7cbd210e389e0, content=with editor 已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Sun Dec 25 10:01:47 CST 2022, time=2022-12-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2021-01-29 14727ed4m21(暂无昵称)

11.29投稿，1.28直接接收，速度很快

120 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务